1-methyl-3-(piperidin-4-yl)imidazolidin-2-one, 95.0%, 1g

(S)-6-Fluorochroman-4-amine, 95.0%, 100mg

4-((S)-2-((S)-2-(6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl (4-nitrophenyl) carbonate, 98%, 1g

(3-(2-Cyanopropan-2-yl)phenyl)boronic acid, 95.0%, 250mg

5-(2,4-Dichlorophenoxymethyl)-1,2-oxazole-3-carboxylic acid, 95%, 5g

4-Hydroxy-1H-indole-3-carbaldehyde, 95.0%, 25g

5-(3-Cyanophenyl)isoxazole-3-carboxylic acid, 95.0%, 100mg

(R)-2-Phenyl-2-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)acetonitrile, 95%, 5g

Silver(I) Benzoate>95.0%(T)5g

Ethylamine (ca. 33% in Water, ca. 6.7mol/L)500mL

2-Bromopyrazolo[1,5-a]pyridine, 98%, 250mg

3,3-Diethylthiacarbocyanine (iodide), 1g

Piperidine, PEPTIPURE®, min. 99.5%, for peptide synthesis, 200 ml, glass packaging